Prof Robert Sutton BA (Hons), MB, BS, DPhil, FRCS

Professor of Surgery Molecular and Clinical Cancer Medicine

    Biography

    Personal Statement

    Leadership in the development and provision of regional hepatopancreatobiliary surgical services for over two decades with personal tertiary referrals from throughout the United Kingdom. Clinical research programme addressing basic, translational and clinical challenges of acute and chronic pancreatitis funded by the National Institute for Health Research, Medical Research Council, Innovate UK and Industry. Service on national and international committees in the field, co-author of national guidelines and contributor to the organisation and faculty membership of many national and international symposia and conferences. Continuing commitment to undergraduate curriculum development, postgraduate training and external examining at all levels in basic biomedical science, clinical science and clinical practice.

    Personal Distinctions

    • Autoimmune pancreatitis: historical perspective, pathogenesis and clinical features (Invitation to Speak, Pancreatic Section 2007)
    • Aberrant calcium signalling in acinar cells (Invitation to Speak, Organising Committee 2007)
    • Invited Lecture (Invitation to Speak, American Pancreatic Association 2006)
    • Invited Lecture (Invitation to Speak, European Pancreatic Club 2006)
    • Invited Lecture (Invitation to Speak, University of Oxford 2005)
    • Invited Lecture (Invitation to Speak, Organising Committee, ENETS 2005)
    • Invited Lecture (Invitation to Speak, UK NET Group 2004)
    • Invited Lecture (Keynote Speech, Irish College of Surgeons 2003)
    • Invited Lecture (Invitation to Speak, Organising Committee, European Pancreatic Club 2003)
    • Invited Lecture (Invitation to Speak, UK NET Group 2003)
    • Invited Lecture (Invitation to Speak, University of Rotterdam 2003)
    • Invited Lecture (Invitation to Speak, International Society of Geriatric Oncology 2003)
    • Invited Lecture (Invitation to Speak, UK NET Group 2002)
    • Invited Lecture (Keynote Speech, Irish Society of Gastroenterology 2002)
    • Invited Lecture (Invitation to Speak, Organising Committee, European Pancreatic Club 2002)
    • Invited Lecture (Invitation to Speak, International Society of Surgery 2001)
    • Invited Lecture (Keynote Speech, National Hepatology Congress 2001)
    • Invited Lecture (Invitation to Speak, Cochrane Hepatobiliary Review Group 2001)
    • Invited Lecture (Invitation to Speak, Executive Committee, Pancreatic Society 2001)
    • Invited Lecture (Invitation to Speak, Cochrane Hepatobiliary Review Group 1999)
    • Invited Lecture (Keynote Speech, Novartis 1999)
    • Invited Lecture (Keynote Speech, Novartis 1999)
    • Invited Lecture (Invitation to Speak, International Society of Pathophysiology 1998)
    • Invited Lecture (Invitation to Speak, Professor Michael Steer 1998)
    • Jacksonian Prize (Royal College of Surgeons of England 1990)
    • Hunterian Professorship (Competitive Fellowship, Royal College of Surgeons of England 1990)
    • Rodney Smith Medal (Pancreatic Society of GB and I 1989)
    • Sir Ernest Finch Research Prize (Trent Regional Health Authority 1987)

    Administrative Roles

    • 1) Council, European Digestive Surgery 2004-7;
    • 2) Referee for Deutsche Forschungsgemeinschaft (German Research Foundation), 2006 et seq; Scottish Executive, 2004 et seq; Czech Ministry of Health, 2001 et seq; Scottish Hospitals Endowment Trust, 2001 et seq; Medical Research Council, 1998 et seq; Wellcome Trust, 1998 et seq; RCS Eng, 1996 et seq; 3) Faculty, American Pancreatic Association, 2004; United European Gastroenterology Week, 2004; Faculty and Organising Committee and Treasurer, European Pancreatic Club, Liverpool 2003, and Heidelberg 2002;
    • 4) Research Awards Committee, CORE (Digestive Disorders Foundation), 2003 et seq; 5) External Advisor, Professorial appointments at Universities in UK, Ghana and Jordan, 2002 et seq;
    • 6) Founder Member and Steering Committee, UK Neuroendocrine Tumour Group, 2000 et seq; Organising Committee UK NET Conferences 2002, UK NET and ENET (European Neuroendocrine Tumour) 2003, UK NET 2004, 2005; 7) Executive Committee, Pancreatic Society GBI; Pancreatic Section, British Society of Gastroenterology, 1998-2001, 2005-9; Research Committee, British Society of Gastroenterology 2005-9;
    • 8) Member of Court of Examiners, Royal College of Surgeons of England, 1997-2003, Chair of Core Module Panel 2001-3, Member of Review Group 2001-2 and Member of Quality Assurance Group 2002-3, contribution to supervision, quality assurance, development, intercollegiate profile of MRCS; Member, Panel of Examiners, Royal College of Surgeons of Edinburgh, 2000-2005; 9) Chairman, Interportal Trials Group, 1996-2000; National and International Adviser, Bayer, Novartis Pharma; Ipsen International, Solvay Pharmaceuticals 1990 et seq. 10) Guidelines Review Panel, Liver Section, British Society of Gastroenterology, 1998 et seq; Pancreatic Section, British Society of Gastroenterology, 1999 et seq; UK Neuroendocrine Group 2000 et seq.

    Untitled Document